Emergen Research Logo

The shortage of human blood for transfusion and rising incidence of accidents and injuries are amongst the significant factors influencing the market growth.

VANCOUER, BC, CANADA, September 22, 2022 /EINPresswire.com/ -- The global Artificial Blood Substitutes Market is projected to worth USD 15.40 Billion by 2027, according to a new report by Emergen Research. The market for synthetic blood substitutes such as Hemopure, Oxyglobin, and Hemotech, is growing at a double-digit rate attributed to its rising application in cardiovascular diseases, anemia, malignant neoplasm, injuries, neonatal conditions, maternal conditions, and organ transplant, among others. Also, obstetric conditions linked with blood transfusion may result in health complications, and even death, if inappropriately managed, is likely to fuel the demand for synthetic blood substitutes.

The shortage of human blood for transfusion and rising incidence of accidents and injuries are amongst the significant factors influencing the Artificial Blood Substitutes market growth.

Every year, more than 4.5 million people in America receive transfusions, owing to a surgical operation or a traumatic injury and the count of patients needing a transfusion is surpassing the number of donors. According to the Pacific Heart, Lung, and Blood Institute, there is an acute shortfall of human blood availability for healthcare purposes.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐓𝐨 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐑𝐞𝐩𝐨𝐫𝐭 :- https://www.emergenresearch.com/request-sample/146

It offers detailed insights into the impact of COVID-19 on the industry at a regional level and industry level. The report also covers the developments and government regulations related to COVID-19. The report further analyzes the current and future impact of COVID-19 on the global market and provides an insight into the post-COVID-19 situation.

𝐒𝐨𝐦𝐞 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 :

In September 2019, a preclinical-stage biotech firm, KaloCyte, engaged in developing a bio-inspired synthetic RBC substitute for application in settings when stored RBCs are not available, has entered into an alliance with the growing biotech community of Baltimore as an affiliate of the University of Maryland (UM) BioPark.

Synthetic hemoglobin-based substitutes are created from hemoglobin collected from a strain of E. coli bacteria. The modified hemoglobin is stable and possesses a more excellent oxygen-carrying ability as compared to RBCs.

Blood transfusions are often administered to patients for the treatment of low hemoglobin levels percutaneous coronary intervention, coronary artery bypass grafting, and non-ST-segment elevation acute coronary syndromes, and settings. Thus, cardiovascular diseases are a major application area for the market.

Contrary to natural blood, with a shelf-life of 42 days, synthetic substitutes may be stored for over a year or more, thereby easing the task of storage and preservation by blood banks and use it when required in blood transfusion.

Europe held the second-largest market share in 2019, owing to the growing demand for synthetic substitutes for blood transfusion in several medical applications, including traumatic injuries & anemia and increased investments in R&D by biotech firms.

Top Companies Profiled in the Artificial Blood Substitutes Market Report Include : Hemarina, Sagart Corporation, FLUORO2 Therapeutics, Biopure Corporation, Alpha Therapeutic Corporation, KaloCyte, Baxter, Green Cross Corporation, North Field Laboratories, and Alliance Pharmaceutical Corporation, among others.

𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬 𝐨𝐧 𝐭𝐨𝐩 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐝𝐚𝐭𝐚 𝐟𝐨𝐫 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐒𝐮𝐛𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 @ https://www.emergenresearch.com/industry-report/synthetic-blood-substitutes-market

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study.

𝐄𝐦𝐞𝐫𝐠𝐞𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐒𝐮𝐛𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐬𝐨𝐮𝐫𝐜𝐞, 𝐭𝐲𝐩𝐞, 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐞𝐧𝐝-𝐮𝐬𝐞, 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐨𝐧:

𝐒𝐨𝐮𝐫𝐜𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧; 𝟐𝟎𝟏𝟕-𝟐𝟎𝟐𝟕)
Human Blood
Animal Blood
Microorganisms
Synthetic Polymers
Stem Cells
Others

𝐓𝐲𝐩𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧; 𝟐𝟎𝟏𝟕-𝟐𝟎𝟐𝟕)
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perfluorocarbon (PFCs)
Others

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧; 𝟐𝟎𝟏𝟕-𝟐𝟎𝟐𝟕)
Cardiovascular Diseases
Anemia
Malignant Neoplasm
Injuries and Trauma
Neonatal Conditions
Maternal Conditions
Organ Transplant
Others

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐒𝐮𝐛𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.emergenresearch.com/request-for-customization/146

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

The global Artificial Blood Substitutes Market has been categorized on the basis of key geographical regions into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. It evaluates the presence of the global Artificial Blood Substitutes Market in the major regions with regards to market share, market size, revenue contribution, sales network and distribution channel, and other key elements

𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐧𝐬𝐰𝐞𝐫𝐬 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐬𝐮𝐜𝐡 𝐚𝐬:

What is the Artificial Blood Substitutes Market size and forecast of the Global Market?

What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Blood Substitutes Market during the forecast period?

Which products/segments/applications/areas to invest in over the forecast period in the Global Artificial Blood Substitutes Market ?

What modes and strategic moves are suitable for entering the Global Artificial Blood Substitutes Market ?

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 @ https://www.emergenresearch.com/request-sample/146

𝐀𝐛𝐨𝐮𝐭 𝐄𝐦𝐞𝐫𝐠𝐞𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Emergen Research is a Market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer Market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

𝐓𝐡𝐚𝐧𝐤 𝐲𝐨𝐮 𝐟𝐨𝐫 𝐫𝐞𝐚𝐝𝐢𝐧𝐠 𝐨𝐮𝐫 𝐫𝐞𝐩𝐨𝐫𝐭. 𝐅𝐨𝐫 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐝𝐞𝐭𝐚𝐢𝐥𝐬 𝐨𝐫 𝐭𝐨 𝐢𝐧𝐪𝐮𝐢𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐥𝐞𝐭 𝐮𝐬 𝐤𝐧𝐨𝐰. 𝐖𝐞 𝐰𝐢𝐥𝐥 𝐨𝐟𝐟𝐞𝐫 𝐲𝐨𝐮 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐬 𝐩𝐞𝐫 𝐲𝐨𝐮𝐫 𝐧𝐞𝐞𝐝𝐬

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.